The treatment of glioblastoma cells with Hepatocyte Growth Factor (HGF) resulted in cMET-AXL co-clustering, AXL phosphorylation at Y779, recruitment of ELMO-DOCK180 complex, RAC1 activation, reorganization of the cytoskeleton, and enhanced cell motility [47]. This evidence concerns the gene AXL and glioblastoma.